The market gave better-than-average returns despite it being ‘an election year’. Investors looking for stability shifted their focus to strong fundamentals and a few promising sectors rather than betting on the overall market. With the economy battling inflation and high interest rates, companies had to find a way to take […]
Dr. Lal PathLabs share price
Additionally, HDFC Securities has assigned an ‘add’ rating to Max Healthcare Institute, Dr. Lal PathLabs, and Metropolis Healthcare, with price targets of ₹900, ₹2,700, and ₹2,010, respectively. The brokerage anticipates that India’s healthcare sector is on track for continuous expansion, driven by factors such as an aging population, a rise […]